Lay Summary Writing for Clinical Trial Disclosure

This training program on clinical trial lay summary writing is designed for legal and regulatory professionals in the pharmaceutical and life sciences sector. It addresses the challenge of meeting mandatory public disclosure requirements while maintaining regulatory accuracy and ethical communication standards. Learners gain the ability to create regulator-compliant, patient-centric lay summaries that withstand inspection and public scrutiny. The program uses regulatory guidance, real submission examples, and structured writing practice to ensure practical application.